Captrust Financial Advisors Pacira Bio Sciences, Inc. Transaction History

Captrust Financial Advisors

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$26.32 - $34.31 $163,684 - $213,373	6,219 New	6,219 $209,000
Q3 2022 Nov 16, 2022	SELL	$51.24 - $58.89 $283,715 - $326,073	-5,537 Reduced 56.95%	4,185 $223,000
Q2 2022 Aug 23, 2022	SELL	$51.49 - $81.64 $17,918 - $28,410	-348 Reduced 3.46%	9,722 $567,000
Q2 2022 Aug 16, 2022	SELL	$51.49 - $81.64 $101,177 - $160,422	-1,965 Reduced 16.33%	10,070 $587,000
Q1 2022 May 16, 2022	BUY	$60.03 - $76.49 $570,224 - $726,578	9,499 Added 374.57%	12,035 $919,000
Q4 2021 Feb 14, 2022	BUY	$47.97 - $62.21 $4,749 - $6,158	99 Added 4.06%	2,536 $153,000
Q3 2021 Nov 16, 2021	SELL	$54.64 - $61.3 $37,537 - $42,113	-687 Reduced 21.99%	2,437 $136,000
Q2 2021 Aug 16, 2021	SELL	$59.18 - $69.99 $284,123 - $336,021	-4,801 Reduced 60.58%	3,124 $190,000
Q1 2021 May 17, 2021	BUY	$59.31 - $78.82 $214,702 - $285,328	3,620 Added 84.09%	7,925 $555,000
Q4 2020 Feb 16, 2021	BUY	$50.47 - $66.26 $18,522 - $24,317	367 Added 9.32%	4,305 $258,000
Q3 2020 Nov 17, 2020	BUY	$51.97 - $63.0 $22,399 - $27,153	431 Added 12.29%	3,938 $236,000
Q2 2020 Aug 14, 2020	BUY	$30.8 - $52.47 $19,927 - $33,948	647 Added 22.62%	3,507 $186,000
Q1 2020 May 15, 2020	BUY	$28.4 - $50.7 $81,224 - $145,002	2,860 New	2,860 $92,000
Q2 2018 Aug 13, 2018	SELL	$27.5 - $39.8 $412 - $597	-15 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$29.98 - $46.35 $449 - $695	15 New	15 $0

263

50.4M

429K

391K

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $892M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

Stay updated on Captrust Financial Advisors with notifications on news.